After pretreatment with 7.5 μM CMEP-NQ for 1 h, J/BCL-XL cells (5 × 105/ml) were treated with 0.3 μM NOC, 1.0 μM 2-MeO-E2, or 0.02 μM CPT for 17 h and then subjected to flow cytometric analysis of cell cycle distribution, Δψm loss, and BAK activation as described in the Materials and Methods. Western blot and flow cytometric analyses were performed as described in the Materials and Methods. A representative result is shown; two additional experiments yielded similar results. Error bars represent standard deviations.</p
<p>(A) Phospho-flow on US7 cells using pErk1/2 (CST) or pMek (BD) antibodies in the left and right p...
<p>(<b>A</b>) MTT-Assay of SW480 and HT29 cells after knockdown of Mcl-1, Bcl-2 and Bcl-x<sub>L</sub...
<p>Cells were treated individually with distinct concentrations (0.5 to 5 µM) of IM. After about two...
After pretreatment with 7.5 μM CMEP-NQ for 1 h, J/Neo cells (5 × 105/mL) were treated with 0.3 μM NO...
After pretreatment with 7.5 μM CMEP-NQ for 1 h, J/Neo cells (5 × 105/mL) were treated with 0.3 μM NO...
<p>(<b>A</b>) Western blot indicating a significant decrease in Bcl-xL protein levels in comparison ...
<p>(A) Western blotting for Bcl-xL and Bcl-2 using lysates from MDA-MB-231 cells treated with DMSO (...
<p>A) Western blotting for apoptotic regulators in A549 cells with CLPTM1L knockdown after treatment...
A-B. Western Blot results for pRB, total CASP7, cleaved CASP7, BCL2, BAX, total CHEK1, pCHEK1, and p...
<p>(A) Western blotting for Bcl-xL and Bcl-2 using lysates from MCF-7 cells treated with DMSO (contr...
<p>(<b>A</b>) Confocal images of immunostaining of bcl-xl (left panel) and cell cycle regulator prot...
<p>Total RNA was extracted from each cell (HEK 293, RTA-expressing HEK 293, induced and uninduced BC...
<p>Cells were treated with 10 µM or 20 µM each of CY2, CY14, CY15 for 24 h or left as such. Cells we...
<p>A) Western blot analysis for AID expression in the subclones analyzed for mutations in panels B a...
<p>SW480 and HT29 cells were transfected with siRNA against Mcl-1, Bcl-2 and Bcl-x<sub>L</sub>. 24 h...
<p>(A) Phospho-flow on US7 cells using pErk1/2 (CST) or pMek (BD) antibodies in the left and right p...
<p>(<b>A</b>) MTT-Assay of SW480 and HT29 cells after knockdown of Mcl-1, Bcl-2 and Bcl-x<sub>L</sub...
<p>Cells were treated individually with distinct concentrations (0.5 to 5 µM) of IM. After about two...
After pretreatment with 7.5 μM CMEP-NQ for 1 h, J/Neo cells (5 × 105/mL) were treated with 0.3 μM NO...
After pretreatment with 7.5 μM CMEP-NQ for 1 h, J/Neo cells (5 × 105/mL) were treated with 0.3 μM NO...
<p>(<b>A</b>) Western blot indicating a significant decrease in Bcl-xL protein levels in comparison ...
<p>(A) Western blotting for Bcl-xL and Bcl-2 using lysates from MDA-MB-231 cells treated with DMSO (...
<p>A) Western blotting for apoptotic regulators in A549 cells with CLPTM1L knockdown after treatment...
A-B. Western Blot results for pRB, total CASP7, cleaved CASP7, BCL2, BAX, total CHEK1, pCHEK1, and p...
<p>(A) Western blotting for Bcl-xL and Bcl-2 using lysates from MCF-7 cells treated with DMSO (contr...
<p>(<b>A</b>) Confocal images of immunostaining of bcl-xl (left panel) and cell cycle regulator prot...
<p>Total RNA was extracted from each cell (HEK 293, RTA-expressing HEK 293, induced and uninduced BC...
<p>Cells were treated with 10 µM or 20 µM each of CY2, CY14, CY15 for 24 h or left as such. Cells we...
<p>A) Western blot analysis for AID expression in the subclones analyzed for mutations in panels B a...
<p>SW480 and HT29 cells were transfected with siRNA against Mcl-1, Bcl-2 and Bcl-x<sub>L</sub>. 24 h...
<p>(A) Phospho-flow on US7 cells using pErk1/2 (CST) or pMek (BD) antibodies in the left and right p...
<p>(<b>A</b>) MTT-Assay of SW480 and HT29 cells after knockdown of Mcl-1, Bcl-2 and Bcl-x<sub>L</sub...
<p>Cells were treated individually with distinct concentrations (0.5 to 5 µM) of IM. After about two...